These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8732443)

  • 1. The safety and tolerability of citalopram.
    Muldoon C
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():35-40. PubMed ID: 8732443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.
    Keller MB
    J Clin Psychiatry; 2000 Dec; 61(12):896-908. PubMed ID: 11206593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram in the treatment of depression.
    Parker NG; Brown CS
    Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice.
    Kyle CJ; Petersen HE; Overø KF
    Depress Anxiety; 1998; 8(4):147-53. PubMed ID: 9871816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.
    Haffmans PM; Timmerman L; Hoogduin CA
    Int Clin Psychopharmacol; 1996 Sep; 11(3):157-64. PubMed ID: 8923094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The side effect burden associated with drug treatment of panic disorder.
    Baldwin DS; Birtwistle J
    J Clin Psychiatry; 1998; 59 Suppl 8():39-44; discussion 45-6. PubMed ID: 9707161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants for insomnia in adults.
    Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram--a review of pharmacological and clinical effects.
    Bezchlibnyk-Butler K; Aleksic I; Kennedy SH
    J Psychiatry Neurosci; 2000 May; 25(3):241-54. PubMed ID: 10863884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does selectivity matter?
    Deakin JF
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():13-7. PubMed ID: 8732439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the safety of citalopram.
    Nemeroff CB
    Psychopharmacol Bull; 2003; 37(1):96-121. PubMed ID: 14561952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
    Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
    Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C
    J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.